Lauro Augusto, Marino Ignazio R, Iyer Kishore R
Liver and Multiorgan Transplant Unit, St. Orsola University Hospital, Alma Mater Studiorum, Bologna, Italy.
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Dig Dis Sci. 2017 Nov;62(11):2966-2976. doi: 10.1007/s10620-017-4752-2. Epub 2017 Sep 16.
Pre-emptive transplantation is a well-established practice for certain types of end-organ failure such as in the use of kidney transplantation. For irreversible intestinal failure, total parenteral nutrition (TPN) remains the gold standard, due to the suboptimal long-term results of intestinal transplantation. As such, the only role for pre-emptive transplantation, if at all, will be for patients identified to be at high risk of complications and mortality while on definitive long-term TPN. In these patients, the timing of early listing and transplantation could become life-saving, taking into account that mortality on the waiting list is still the highest for intestinal candidates. The development of simulation models or pre-transplant scoring systems could help in selecting patients based on potential outcome on TPN or with transplantation, and recent reports from high-volume centers identify few underlying pathologic conditions and some TPN complications as at higher risk of increased morbidity and mortality. A pre-emptive transplant could be used as a rehabilitative procedure in a well-selected case-by-case scenario, among TPN patients at risk of liver failure, repeated central line infections, mesenteric infarction, short bowel syndrome (SBS) <50 cm or with end stoma, congenital mucosal disease, desmoid tumors: These conditions must be carefully evaluated, not to underestimate the clinical stage nor to over-estimate the impact of a temporary situation. At the present time, diseases with a variable and unpredictable course, such as intestinal dysmotility disorders, or quality of life and financial issues are still far from being considered as indications for a pre-emptive transplant.
对于某些类型的终末期器官衰竭,如肾移植,抢先移植是一种既定的做法。对于不可逆的肠衰竭,由于肠移植长期效果欠佳,全胃肠外营养(TPN)仍是金标准。因此,抢先移植(如果有作用的话)的唯一作用将是针对那些在接受长期确定性TPN治疗时被确定有高并发症和死亡风险的患者。对于这些患者,考虑到肠移植候选者在等待名单上的死亡率仍然是最高的,早期列入名单和移植的时机可能会挽救生命。模拟模型或移植前评分系统的开发有助于根据TPN或移植的潜在结果来选择患者,高容量中心的最新报告指出,很少有潜在病理状况和一些TPN并发症会有更高的发病率和死亡率风险。在精心挑选的逐案情况下,对于有肝衰竭风险、反复发生中心静脉导管感染、肠系膜梗死、短肠综合征(SBS)<50 cm或有末端造口、先天性黏膜疾病、硬纤维瘤的TPN患者,抢先移植可作为一种康复程序:这些情况必须仔细评估,既不能低估临床阶段,也不能高估临时情况的影响。目前,病程多变且不可预测的疾病,如肠道动力障碍,或生活质量和经济问题,仍远未被视为抢先移植的指征。